Sectors

LPCN
Lipocine Inc.
2.24
2 x 1.51
2 x 2.81
bid
ask
+
0.07
3.23%
2 @ 04:49 PM
2.22 -0.02 (0.89%)
Ytd-72.10%
1y-23.02%
2.14
day range
2.27
1.81
52 week range
12.37
Open2.14Prev Close2.17Low2.14High2.27Mkt Cap18.47M
Vol27.53KAvg Vol62.19KEPS-1.85P/EN/AForward P/E-3.87
Beta1.19Short Ratio2.80Inst. Own9.96%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1450-d Avg2.23200-d Avg4.521yr Est21.50
Income Statement
Total Revenue190.10K
Revenues (USD)190.10K
Gross Profit190.10K
Operating Expenses3.03M
Research and Development Expense2.04M
Selling, General and Administrative Expense990.96K
Operating Income-2.84M
Income Tax Expense200.00
Net Income-2.62M
Net Income Common Stock-2.62M
Net Income Common Stock (USD)-2.62M
Consolidated Income-2.62M
Earnings per Basic Share-0.32
Earnings per Basic Share (USD)-0.32
Earnings per Diluted Share-0.32
Earning Before Interest & Taxes (EBIT)-2.62M
Earning Before Interest & Taxes (USD)-2.62M
Weighted Average Shares8.22M
Weighted Average Shares Diluted8.22M
Balance Sheet
Cash and Equivalents4.98M
Cash and Equivalents (USD)4.98M
Investments18.29M
Investments Current18.29M
Trade and Non-Trade Receivables190.10K
Current Assets23.74M
Property, Plant & Equipment Net74.83K
Total Assets23.84M
Current Liabilities2.07M
Total Liabilities2.07M
Accumulated Retained Earnings (Deficit)-215.69M
Accumulated Other Comprehensive Income-13.40K
Shareholders Equity21.77M
Shareholders Equity (USD)21.77M
Assets Non-Current98.58K
Deferred Revenue320.00K
Trade and Non-Trade Payables680.53K
Cash Flow
Depreciation, Amortization & Accretion14.65K
Net Cash Flow from Financing1.51M
Net Cash Flow / Change in Cash & Cash Equivalents-36.18K
Issuance (Purchase) of Equity Shares1.51M
Net Cash Flow from Investing1.48M
Net Cash Flow - Investment Acquisitions and Disposals1.48M
Net Cash Flow from Operations-3.03M
Share Based Compensation58.15K